In our study, we aimed at fine-mapping the original GWAS signal, rs710521, within the TP63/LEPREL1 gene locus and, subsequently, at a functional characterization of genetic variants within this locus that are associated with bladder cancer risk. The gene discussed is TP63; the disease is urinary bladder cancer.